FOLH1 and carcinoma: First results in humans were obtained by Hope et al. (2017), when a seven-fold increase of PSMA after treatment with leuprolide acetate and bicalutamide of castration-sensitive carcinoma was reported by [68Ga]Ga-PSMA-11-PET.